To evaluate the efficacy of daily potassium intake on decreasing blood pressure in non-medicated normotensive or hypertensive patients, and to determine the relationship between potassium intake, sodium-to-potassium ratio and reduction in blood pressure.
Mixed-effect meta-analyses and meta-regression models.
Medline and the references of previous meta-analyses.
Randomized controlled trials with potassium supplementation, with blood pressure as the primary outcome, in non-medicated patients.
Fifteen randomized controlled trials of potassium supplementation in patients without antihypertensive medication were selected for the meta-analyses (917 patients). Potassium supplementation resulted in reduction of SBP by 4.7 mmHg [95% confidence interval (CI) 2.4–7.0] and DBP by 3.5 mmHg (95% CI 1.3–5.7) in all patients. The effect was found to be greater in hypertensive patients, with a reduction of SBP by 6.8 mmHg (95% CI 4.3–9.3) and DBP by 4.6 mmHg (95% CI 1.8–7.5). Meta-regression analysis showed that both increased daily potassium excretion and decreased sodium-to-potassium ratio were associated with blood pressure reduction (P < 0.05). Increased total daily potassium urinary excretion from 60 to 100 mmol/day and decrease of sodium-to-potassium ratio were shown to be necessary to explain the estimated effect.
Potassium supplementation is associated with reduction of blood pressure in patients who are not on antihypertensive medication, and the effect is significant in hypertensive patients. The reduction in blood pressure significantly correlates with decreased daily urinary sodium-to-potassium ratio and increased urinary potassium. Patients with elevated blood pressure may benefit from increased potassium intake along with controlled or decreased sodium intake.
Supplemental Digital Content is available in the text
aNutrition & Health Research
bClinical Development Unit
cPublic Health Nutrition, Nestlé Research Centre, Lausanne, Switzerland
Correspondence to Dr Aristea Binia, Nestlé Research Center, P.O. Box 44, Vers-chez-les-Blanc, CH-1000 Lausanne 26, Switzerland. Tel: +41 21 785 8278; fax: +41 21 785 8554; e-mail: firstname.lastname@example.org
Abbreviations: ABPM, ambulatory blood pressure monitoring; BP, blood pressure; CI, confidence interval; K, potassium; KCl, potassium chloride; KHCO3, potassium bicarbonate; MEDLIN, Medical Literature Analysis and Retrieval System Online; MeSH, Medical Subject Headings; Na, sodium; Na/K, sodium-to-potassium ratio; RCT, randomized controlled trial
Received 11 August, 2014
Revised 26 March, 2015
Accepted 26 March, 2015
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (http://www.jhypertension.com).